Chen Qian. Salbutamol and Ipratropium Bromide Combined with Magnesium Sulfate in the Treatment of Children with Acute Attack of Bronchial Asthma[J]. 2020,26(7):31-34.
Chen Qian. Salbutamol and Ipratropium Bromide Combined with Magnesium Sulfate in the Treatment of Children with Acute Attack of Bronchial Asthma[J]. 2020,26(7):31-34. DOI: 10.13407/j.cnki.jpp.1672-108X.2020.07.010.
Objective: To probe into the efficacy of salbutamol and ipratropium bromide combined with magnesium sulfate in the treatment of children with acute attack of bronchial asthma. Methods: Totally 106 children with acute attack of bronchial asthma admitted into our hospital from Mar. 2018 to Feb. 2019 were extracted to be divided into the control group and the observation group via the random number table
with 53 cases in each group. The control group was treated with aerosol inhalation of ipratropium bromide combined with salbutamol
while the observation group received aerosol inhalation of ipratropium bromide combined with salbutamol and intravenous injection of magnesium sulfate. The clinical efficacy
pulmonary function index
serological index and adverse drug reactions of two groups were observed. Results: The total effective rate of the observation group was higher than that of the control group (P<0.05). The disappearance time of wheezing
shortness of breath
cough and other symptoms
the length of stay in the observation group were shorter than those in the control group (P<0.05). After treatment
the first-second forced expiratory volume (FEV1) and maximum expiratory peak flow rate (PEF) in two groups were significantly higher than those before treatment
and the improvement of all indicators in the observation group was more significant (P<0.05). After treatment
the levels of immunoglobulin E (IgE) in two groups were significantly lower than those before treatment
and the reduction in the observation group was more significant (P<0.05). There was no significant difference in the incidence of adverse drug reactions between two groups (P>0.05). Conclusion: Salbutamol
ipratropium bromide combined with magnesium sulfate in the treatment of acute attack of bronchial asthma in children is significantly better than salbutamol combined with ipratropium bromide
which can improve the clinical efficacy
shorten the improvement time of clinical symptoms
reduce the levels of IgE and improve patients’ pulmonary function.